Period and Intimate Care Product Lawsuits

What These Claims Allege

This cluster covers products used in prolonged contact with mucosal or absorptive tissue, where published testing has reported contaminants that consumers say were never disclosed. The route of exposure is what distinguishes them from ordinary consumer claims.

The specific allegations include heavy metals detected in tampons, PFAS in reusable period underwear marketed as non-toxic, and benzene contamination identified in aerosolised personal care products.

Economic Loss and Disclosure

Most of these claims are economic rather than injury claims. The theory is that consumers paid for products represented as safe, organic or free of particular chemicals, and would not have paid the same price had the contamination been disclosed.

Framing them as economic claims avoids the difficulty of proving that a specific product caused a specific illness in an individual, which is why they certify as class actions far more readily than injury claims would.

Cases Covered in This Section

This section tracks 5 active or resolved matters. Each has its own detailed page covering the allegations, who may qualify, and what the process involves.

• Cora Pads Lawsuit: Can You File a Claim in This Case?
• L-Pads Lawsuit: Menstrual Product Claims & Consumer Protection
• Is the Cora Tampons Lawsuit Legit? Key Legal Insights
• Rael Pads Lawsuit Settlement Update: Everything We Know
• Thinx Lawsuit: PFAS and Chemical Claims in Period Underwear

Who May Have a Claim

Purchasers of the identified products during the relevant period generally qualify for the economic claims. No injury or medical diagnosis is required, and receipts are usually helpful but not essential for a basic claim.

Injury claims, where brought, require a documented condition and evidence connecting it to the product, which is substantially harder given the difficulty of isolating one source of exposure among many.

Testing Evidence and Timing

These cases typically begin with published independent laboratory testing rather than with a regulator. That testing is what identifies the products and frames the claim, and disputes over methodology are common early.

Because the products are inexpensive and widely purchased, individual recoveries in settlements are usually small, with the more consequential outcomes being reformulation and disclosure commitments.